Neuropathology of Parkinsonism in Patients with Pure Alzheimer's Disease
|Published in||Journal of Alzheimer's disease : JAD. 2014, vol. 39, no. 1, p. 115-120|
|Abstract||About one third of Alzheimer's disease (AD) patients develop some parkinsonian features, yet half of them do not have Lewy body pathology at autopsy. The neuropathological substrate of parkinsonism in AD is still unclear. In the present study, we measured neuronal and neurofibrillary tangles (NFTs) densities in the substantia nigra pars compacta (SN) and in the putamen of 22 AD patients, 11 with and 11 without parkinsonism, here defined as the presence of bradykinesia and at least one of resting tremor, rigidity, or gait disorders. Our study showed that parkinsonism associated with AD was related to a significant loss of neurons both in the SN and in the putamen, suggesting pre-and postsynaptic alterations of the nigrostriatal pathway. Neuronal tau deposition was a less important factor as density of NFTs correlated with parkinsonism only in the SN but not in the putamen. We propose that a subgroup of pure AD patients develop parkinsonian symptoms as a result of neuronal loss in the basal ganglia, indicating a prominent subcortical involvement, which appears unrelated to the Braak stage of AD.|
This document has no fulltext available yet, but you can contact its author by using the form below.
|Research groups||Groupe Bouras Constantin (neuropsychiatrie) (1)|
Démence du sujet âgé, troubles cognitifs, la symptomatologie cognitive (577)
Groupe Pierre Burkhard (neurologie) (154)
|HORVATH, Judit et al. Neuropathology of Parkinsonism in Patients with Pure Alzheimer's Disease. In: Journal of Alzheimer's disease : JAD, 2014, vol. 39, n° 1, p. 115-120. doi: 10.3233/JAD-131289 https://archive-ouverte.unige.ch/unige:33301|